Compared with baseline, BCSs experienced significant reductions in most of the metabolic and inflammatory parameters analyzed, including those related to insulin resistance (i.e., glycemia, insulin, and HOMA-IR) and inflammation (hs-CRP). The gene discussed is INS; the disease is Insulin resistance.